Health Products

Bortezomib for Injection (2016-03-18)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
1600615Bortezomib for Injection
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Powder for solutionDIN 024234053.5 mg/vial

Introduction

Affected Products

Bortezomib for Injection

Reason

Potential for presence of particulate matter (glass) in this lot.

Depth of distribution

Wholesalers, hospitals - Quebec, British Columbia, Saskatchewan, Manitoba, Ontario, Newfoundland and Labrador
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime